Secretion of inhibitory cytokines (None)

"Secretion of inhibitory cytokines" refers to the biological process by which certain cells—primarily within the immune system—release proteins known as inhibitory or anti-inflammatory cytokines. These molecules act locally or systemically to suppress inflammatory responses and maintain immune homeostasis by counteracting proinflammatory signals. Key examples include interleukin‑10 (IL‑10) and transforming growth factor-beta (TGF‑β), among others. This regulatory mechanism prevents excessive tissue damage during inflammation but can also contribute to disease processes if dysregulated—for example, leading either to autoimmunity when insufficiently active or impaired pathogen/tumor clearance when overactive. In summary, "secretion of inhibitory cytokines" should be considered a biological function/process, not an individual druggable target molecule/receptor suitable for structured database entries under canonical naming conventions.

Other names

Inhibitory cytokine secretionAnti-inflammatory cytokine releaseImmunosuppressive cytokine production

Not applicable as this is not one molecule; mechanisms include: Upregulation/downregulation via transcriptional control, Receptor agonism/antagonism for individual anti-inflammatory pathways. Examples: Glucocorticoids bind glucocorticoid receptors and increase transcription of anti-inflammatory genes including some inhibitory cytokines. Biologics may block proinflammatory signals indirectly increasing relative activity/effectiveness of endogenous inhibitors.